Skip to main content
Back
BTSG logo

BrightSpring Health Services, Inc. Common Stock

Data quality: 100%
BTSG
NASDAQ Healthcare Medical - Healthcare Information Services
$42.10
▲ $0.89 (2.16%)
Mkt Cap: 8.15B
Day Range
$41.40 $43.26
52-Week Range
$15.48 $44.87
Volume
2,743,497
50D / 200D Avg
$40.00 / $31.00
Prev Close
$41.21

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 42.7 0.4
P/B 4.4 2.9
ROE % 10.8 3.8
Net Margin % 1.5 3.9
Rev Growth 5Y % 17.8 10.0
D/E 1.5 0.2

Key Takeaways

Revenue grew 17.83% annually over 5 years — strong growth
ROE of 10.82% — decent returns on equity
Generating 394.69M in free cash flow
P/E of 42.74 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.24%
Cash machine — converts 207.00% of earnings into free cash flow

Growth

Revenue Growth (5Y)
17.83%
Revenue (1Y)14.59%
Earnings (1Y)N/A
FCF Growth (3Y)69.57%

Quality

Return on Equity
10.82%
ROIC6.29%
Net Margin1.48%
Op. Margin3.06%

Safety

Debt / Equity
1.52
Current Ratio1.57
Interest Coverage2.51

Valuation

P/E Ratio
42.74
P/B Ratio4.35
EV/EBITDA27.57
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 14.59% Revenue Growth (3Y) 20.94%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 17.83% Earnings Growth (5Y) 39.88%
Profitability
Revenue (TTM) 12.91B Net Income (TTM) 190.67M
ROE 10.82% ROA 2.97%
Gross Margin 11.76% Operating Margin 3.06%
Net Margin 1.48% Free Cash Flow (TTM) 394.69M
ROIC 6.29% FCF Growth (3Y) 69.57%
Safety
Debt / Equity 1.52 Current Ratio 1.57
Interest Coverage 2.51 Dividend Yield 0.00%
Valuation
P/E Ratio 42.74 P/B Ratio 4.35
P/S Ratio 0.63 PEG Ratio -0.04
EV/EBITDA 27.57 Dividend Yield 0.00%
Market Cap 8.15B Enterprise Value 10.90B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 12.91B 11.27B 8.83B 7.72B 6.70B
Net Income 190.67M -18.06M -154.60M -53.91M 49.80M
EPS (Diluted) 0.87 -0.09 -0.90 -0.31 0.29
Gross Profit 1.52B 1.59B 1.43B 1.35B 1.25B
Operating Income 395.46M 206.37M 147.18M 187.83M 234.18M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6.41B 5.93B 5.53B 5.44B 5.51B
Total Liabilities 4.53B 4.27B 4.92B 4.66B 4.71B
Shareholders' Equity 1.88B 1.65B 584.74M 754.78M 774.82M
Total Debt 2.84B 2.90B 3.67B 3.68B 3.77B
Cash & Equivalents 88.37M 61.25M 13.07M 13.63M 46.74M
Current Assets 2.89B 1.89B 1.46B 1.34B 1.18B
Current Liabilities 1.85B 1.43B 1.25B 932.51M 892.16M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#160 of 616
53

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026